Effect of Renal Sympathetic Denervation on Atrial Substrate Remodeling in Ambulatory Canines with Prolonged Atrial Pacing

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Wang, Xule ^a,b   Zhao, Qingyan ^a,b   Huang, He ^a,b   Tang, Yanhong ^a,b   Xiao, Jinping ^a,b   Dai, Zixuan ^a,b   Yu, Shengbo ^a,b   Huang, Congxin ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CASPASE 3; INTERLEUKIN 6; NEUROMODULIN; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL HEART PACEMAKER; CHRONIC DISEASE; CONTROLLED STUDY; DOG; DOWN REGULATION; HEART ATRIUM APPENDAGE; HEART ATRIUM PACING; HEART MUSCLE FIBROSIS; HEART SURGERY; IMMUNOHISTOCHEMISTRY; KIDNEY DENERVATION; NONHUMAN; PROTEIN BLOOD LEVEL; THERAPY EFFECT; TREATMENT DURATION; UPREGULATION; ANIMAL; APOPTOSIS; ATRIAL FIBRILLATION; BLOOD; BLOOD PRESSURE; FIBROSIS; GAP JUNCTION; HEART ATRIUM; HEART ATRIUM REMODELING; HEART MUSCLE CELL; HEART PACING; INFLAMMATION; INNERVATION; KIDNEY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SURGERY; SYMPATHECTOMY;

CANIS FAMILIARIS;

ALDOSTERONE; ANGIOTENSIN II; ANIMALS; APOPTOSIS; ATRIAL FIBRILLATION; ATRIAL NATRIURETIC FACTOR; ATRIAL REMODELING; BLOOD PRESSURE; CARDIAC PACING, ARTIFICIAL; DOGS; FIBROSIS; GAP JUNCTIONS; GAP-43 PROTEIN; HEART ATRIA; INFLAMMATION; INTERLEUKIN-6; KIDNEY; MYOCYTES, CARDIAC; SYMPATHECTOMY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878268633     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064611     Document Type: Article

References (45)

1. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM, (2007) Renin-angiotensin system and cardiovascular risk. Lancet 369: 1208-19.
2. Iravanian S, Dudley SC, (2008) The Renin-Angiotensin-Aldosterone System (RAAS) and Cardiac Arrhythmias. Heart Rhythm 5: s12-s17.
3. Boldt A, Wetzel U, Weigl J, Garbade J, Lauschke J, et al. (2003) Expression of Angiotensin II Receptors in Human Left and Right Atrial Tissue in Atrial Fibrillation With and Without Underlying Mitral Valve Disease. J Am Coll Cardiol 42: 1785-92.
4. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, et al. (2005) Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis. J Am Coll Cardiol 45: 1832-39.
5. Madrid AH, Bueno MG, Rebollo JM, Marin I, Pena G, et al. (2002) Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study. Circulation 106: 331-6.
6. Belluzzi F, Sernesi L, Preti P, Salinaro F, Fonte ML, et al. (2009) Prevention of Recurrent Lone Atrial Fibrillation by the Angiotensin-II Converting Enzyme Inhibitor Ramipril in Normotensive Patients. J Am Coll Cardiol 53: 24-29.
7. Schneider MP, Hua TA, Bohm M, Wachtell K, Kjeldsen SE, et al. (2010) Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition: A Meta-Analysis. J Am Coll Cardiol 55: 2299-2307.
8. Patlolla V, Alsheikhali AA, Alahmad AM, (2006) The Renin-Angiotensin System: A Therapeutic Target in Atrial Fibrillation. PACE 29: 1006-12.
9. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, et al. (2000) Angiotensin II Antagonist Prevents Electrical Remodeling in Atrial Fibrillation. Circulation 101: 2612-17.
10. Fukuda Y, Fukuda N, Morishita S, Tamura Y, (2011) Preventive effect of renin-angiotensin system inhibitor on left atrial remodelling in patients with chronic atrial fibrillation: long-term echocardiographic study. European Journal of Echocardiography 12: 278-282.
11. Morillo CA, Klein GJ, Jones DL, Guiraudon CM, (1995) Chronic Rapid Atrial Pacing: Structural, Functional, and Electrophysiological Characteristics of a New Model of Sustained Atrial Fibrillation. Circulation 91: 1588-95.
12. Zhao J, Li J, Li W, Li Y, Shan H, et al. (2010) Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing. British Journal of Pharmacology 159: 1584-94.
13. Van der Velden HM, Ausma J, Rook MB, Hellemons AJ, Van veen TA, et al. (2000) Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 46: 476-486.
14. Chang C-M, Wu T-J, Zhou S-M, Doshi RN, Lee M-H, et al. (2001) Nerve sprouting and symathetic hyperinnervation in a canine model of atrial fibrillation produced by prolonged right atrial pacing. Circulation 103: 22-25.
15. Engelmann MD, Svendsen JH, (2005) Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 26: 2083-92.
16. Kiryu M, Niwano S, Niwano H, Kishihara J, Aoyama Y, et al. (2012) Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model. Europace 14: 1206-14.
17. Kasal DAB, Schiffrin EL, (2012) Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities. Int J Hypertens 2012: 132598-612.
18. Velez Rueda JO, Palomeque J, Mattiazzi A, (2012) Early apoptosis in different models of cardiac hypertrophy induced by high renin-angiotensin system activity involves CaMKII. J Appl Physiol 112 (12): 2110-20.
19. Sarkissian SD, Marchand EL, Duguay D, Hamet P, deBlois D, (2003) Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril. Cardiovas Res 57: 775-83.
20. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, et al. (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373: 1275-81.
21. Esler M, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, et al. (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 373: 1903-9.
22. Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, et al. (2013) First-in-man safety evaluation of renal denervation for chronic systolic heart failure: Primary outcome from REACH-Pilot study. Int J Cardiol 162(3): 189-92.
23. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, et al. (2011) Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension. J Am Coll Cardiol 59: 901-9.
24. Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, et al. (2012) A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol 60: 1163-70.
25. Hu J, Ji M, Niu C, Aini A, Zhou Q, et al. (2012) Effects of Renal Sympathetic Denervation on Post-Myocardial Infarction Cardiac Remodeling in Rats. PLOS ONE 7(9): e45986-91.
26. Zhao Q, Yu S, Zou M, Dai Z, Wang X, et al. (2012) Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing. J Interv Card Electrophysiol 35(2): 119-125.
27. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA, (1995) Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 92: 1954-68.
28. Zhang Y, Yamada H, Bibevski S, Zhuang S, Mowrey K, et al. (2005) Chronic Atrioventricular Nodal Vagal Stimulation First Evidence for Long-Term Ventricular Rate Control in Canine Atrial Fibrillation Model. Circulation 112: 2904-11.
29. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD, (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361: 932-934.
30. Boos CJ, Anderson RA, Lip GY, (2006) Is atrial fibrillation an inflammatory disorder? Eur Heart J 27(2): 136-149.
31. Stambler BS, Guo GB, (2005) Atrial Natriuretic Peptide Has Dose-Dependent, Autonomically Mediated Effects on Atrial Refractoriness and Repolarization in Anesthetized Dogs. J Cardiovasc Electrophysiol 16: 1341-47.
32. Cao H, Xue L, Wu Y, Ma H, Chen L, et al. (2010) Natriuretic peptides and right atrial fibrosis in patients with paroxysmal versus persistent atrial fibrillation. Peptides 31: 1531-39.
33. Aimé-Sempé C, Folliguet T, Rücker-Martin C, Krajewska M, Krajewskai S, et al. (1999) Myocardial Cell Death in Fibrillating and Dilated Human Right Atria. J Am Coll Cardiol 34: 1577-86.
34. Mano A, Tatsumi T, Shiraishi J, Keira N, Nomura T, et al. (2004) Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways. Circulation 110: 317-323.
35. Burniston JG, Saini A, Tan LB, Goldspink DF, (2005) Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo. J Mol Cell Cardiol 39: 395-399.
36. Harada E, Yoshimura M, Yasue H, Nakagawa O, Nakagawa M, et al. (2001) Aldosterone Induces Angiotensin-Converting-Enzyme Gene Expression in Cultured Neonatal Rat Cardiocytes. Circulation 104: 137-139.
37. Duffy HS, Wit AL, (2008) Is there a role for remodeled connexins in AF? No simple answers. J Mol Cell Cardiol 44: 4-13.
38. Polontchouk L, Haefliger JA, Ebelt B, Schaefer T, Stuhlmann D, et al. (2001) Effects of Chronic Atrial Fibrillation on Gap Junction Distribution in Human and Rat Atria. J Am Coll Cardiol 38: 883-891.
39. Ausma J, van der Velden HM, Lenders MH, van Ankeren EP, Jongsma HJ, et al. (2003) Reverse Structural and Gap-Junctional Remodeling After Prolonged Atrial Fibrillation in the Goat. Circulation 107: 2051-58.
40. Chanson M, Berclaz PY, Scerri I, Dudez T, Wernke-Dollries K, et al. (2001) Regulation of gap junctional communication by a pro-inflammatory cytokine in cystic fibrosis transmembrane conductance regulator-expressing but not cystic fibrosis airway cells. Am J Pathol 158 (5): 1775-84.
41. Jayachandran JV, Sih HJ, Winkle W, Zipes DP, Hutchins GD, et al. (2000) Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation 101: 1185-91.
42. Tan AY, Zhou S, Ogawa M, Song J, Chu M, et al. (2008) Neural Mechanisms of Paroxysmal Atrial Fibrillation and Paroxysmal Atrial Tachycardia in Ambulatory Canines. Circulation 118: 916-25.
43. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, et al. (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347: 1825-33.
44. Pappone C, Santinelli V, Manguso F, Vicedomini G, Guqliotta F, et al. (2004) Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 109: 327-34.
45. Katritsis DG, Giazitzoglou E, Zografos T, Pokushalov E, Po SS, et al. (2011) Rapid pulmonary vein isolation combined with autonomic ganglia modification: a randomized study. Heart Rhythm 8(5): 672-8.